Abstract:The link between cellular exposure to fatty acid species and toxicity phenotypes remains poorly understood. However, structural characterization and functional profiling of human plasma free fatty acids (FFAs) analysis has revealed that FFAs are located either in the toxic cluster or in the cluster that is transcriptionally responsive to lipotoxic stress and creates genetic risk factors. Genome-wide short hairpin RNA screen has identified more than 350 genes modulating lipotoxicity. Hypertrophic adipocytes in obese adipose are both unable to expand further to store excess lipids in the diet and are resistant to the antilipolytic action of insulin. In addition to lipolysis, the inability of packaging the excess lipids into lipid droplets causes circulating fatty acids to reach toxic levels in non-adipose tissues. Deleterious effects of accumulated lipid in non-adipose tissues are known as lipotoxicity. Although triglycerides serve a storage function for long-chain non-esterified fatty acid and their products such as ceramide and diacylglycerols (DAGs), overloading of palmitic acid fraction of saturated fatty acids (SFAs) raises ceramide levels. The excess DAG and ceramide load create harmful effects on multiple organs and systems, inducing chronic inflammation in obesity. Thus, lipotoxic inflammation results in β cells death and pancreatic islets dysfunction. Endoplasmic reticulum stress stimuli induce lipolysis by activating cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) and extracellular signal-regulated kinase (Erk) 1/2 signaling in adipocytes. However, palmitic acid-induced endoplasmic reticulum stress-c-Jun N-terminal kinase (JNK)-autophagy axis in hypertrophic adipocytes is a pro-survival mechanism against endoplasmic reticulum stress and cell death induced by SFAs. Endoplasmic reticulum-localized acyl-coenzyme A (CoA): glycerol-3-phosphate acyltransferase (GPAT) enzymes are mediators of lipotoxicity, and inhibiting these enzymes has therapeutic potential for lipotoxicity. Lipotoxicity increases the number of autophagosomes, which engulf palmitic acid, and thus suppress the autophagic turnover. Fatty acid desaturation promotes palmitate detoxification and storages into triglycerides. As therapeutic targets of glucolipotoxicity, in addition to caloric restriction and exercise, there are four different pharmacological approaches, which consist of metformin, glucagon-like peptide 1 (GLP-1) receptor agonists, peroxisome proliferator-activated receptor-gamma (PPARγ) ligands thiazolidinediones, and chaperones are still used in clinical practice. Furthermore, induction of the brown fat-like phenotype with the mixture of eicosapentanoic acid and docosahexaenoic acid appears as a potential therapeutic application for treatment of lipotoxicity.

Abstract 19447: Glycogen Synthase Kinase-3a Regulates Fatty Acid Metabolism Through PPARa Phosphorylation That Underlies Lipotoxic Cardiomyopathy

FABP3 Deficiency Exacerbates Metabolic Derangement in Cardiac Hypertrophy and Heart Failure via PPARα Pathway

PAK3 Exacerbates Cardiac Lipotoxicity via SREBP1c in Obesity Cardiomyopathy

Deranged Myocardial Fatty Acid Metabolism in Heart Failure

Lipid metabolism and signaling in cardiac lipotoxicity

Role of 14-3-3η protein on cardiac fatty acid metabolism and macrophage polarization after high fat diet induced type 2 diabetes mellitus

Abstract 279: Increased Drp1 Acetylation Mediates Lipid Overload-induced Cardiomyocyte Death & Heart Dysfunction

Mechanism of Obesity-Related Lipotoxicity and Clinical Perspective

A critical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: Modulation by dietary fat content

Deacetylase‐dependent and ‐independent role of HDAC3 in cardiomyopathy

Elucidation of the Role of a Lysine Demyristoylase in Adipose Tissue‐myocardium Crosstalk in Cardiometabolic Disease

Integrated Control of Fatty Acid Metabolism in Heart Failure

Abstract P3175: Mitochondrial Fission And Extracellular Mitochondria Mediate Cardiac Dysfunction In Obesity Induced Cardiomyopathy

Abstract 15465: Upregulation of Mitochondrial Atpase Inhibitory Factor 1 Mediates Increased Glycolysis in Pathological Cardiac Hypertrophy

Obesity-induced activation of JunD promotes myocardial lipid accumulation and metabolic cardiomyopathy

Ketone Bodies Rescue Mitochondrial Dysfunction Via Epigenetic Remodeling

Lipotoxicity as a therapeutic target in obesity and diabetic cardiomyopathy

Glucolipotoxicity diminishes cardiomyocyte TFEB and inhibits lysosomal autophagy during obesity and diabetes

Deletion of Protein Tyrosine Phosphatase 1B Rescues Against Myocardial Anomalies in High Fat Diet-Induced Obesity: Role of AMPK-dependent Autophagy.

Abstract 075: Ketone Bodies Rescue Mitochondrial Dysfunction And Improve Maladaptive Epigenetic Remodeling In Heart Failure

Phosphorylation of Beta-3 Adrenergic Receptor at Serine 247 by ERK MAP Kinase Drives Lipolysis in Obese Adipocytes